Robin Alderman faces an agonizing reality: Gene therapy might cure her son Camden’s rare, inherited immune deficiency. But it’s not available to him. In 2022, London-based Orchard Therapeutics stopped investing in an experimental treatment for the condition, Wiskott-Aldrich syndrome. And there are no gene therapy studies he can join. “We feel like we are the […]
The Nvidia (NVDA) juggernaut continues as the artificial intelligence giant looks to topple Apple (AAPL) and take on Microsoft (MSFT) for supremacy in terms of market capitalization. And as Nvidia stock looks to hit yet another record high, it joins semiconductor powerhouses Taiwan Semiconductor (TSM) and Advanced Micro Devices (AMD) on IBD Leaderboard as they […]
When Brad Miller became the chief information officer at drugmaker Moderna in early 2023, he already had a strong background in finance and technology, but no expertise in health care. “Learning about pharma and biotech was really critical,” says Miller, who had previously been CIO at Capital One, held leadership roles at Mastercard, and spent […]